Top

World Journal of Urology

Published in:

01-09-2018 | Invited Review

Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis

Authors: Zheng Deng, Menghao Sun, Yiping Zhu, Jian Zhuo, Fujun Zhao, Shujie Xia, Bangmin Han, Thomas R. W. Herrmann

Published in: World Journal of Urology | Issue 9/2018

Abstract

Purpose

To compare the efficacy and safety of thulium laser VapoResection of the prostate (ThuVaRP) versus standard traditional transurethral resection of the prostate (TURP) or plasmakinetic resection of prostate (PKRP) for benign prostatic obstruction.

Methods

Systematic searches were performed in the Medline, EMBASE, the Cochrane Library, Web of Science, and CNKI in December 2017. The outcomes of demographic and clinical characteristics, perioperative variables, complications, and postoperative efficacy including International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Qmax), and postvoid residual (PVR) were assessed.

Results

16 studies were selected in the meta-analysis including nine randomized controlled trials (RCTs) and seven non-RCTs. Among of them, nine studies compared ThuVaRP with PKRP, while seven studies compared ThuVaRP with TURP. It seemed that ThuVaRP needed longer operation time than TURP (WMD = 6.41, 95% CI 1.38–11.44, p = 0.01) and PKRP (WMD = 10.15, 95% CI 5.20–15.10, p < 0.0001). ThuVaRP was associated with less serum hemoglobin decreased, catheterization time, and the length of hospital stay compared with TURP (WMD = − 0.58, 95% CI − 0.77 to 0.38, p < 0.00001; WMD = − 1.89, 95% CI − 2.67 to 1.11, p < 0.00001; WMD = − 2.25, 95% CI − 2.91 to 1.60, p < 0.00001) and PKRP (WMD = − 0.28, 95% CI − 0.46 to 0.10, p = 0.002; WMD = − 1.88, 95% CI − 2.87 to 0.89, p = 0.0002; WMD = − 2.08, 95% CI − 2.63 to 1.54, p<0.00001). According to our assessment, there was no significantly difference in postoperative efficacy.

Conclusions

The pooled data indicated that ThuVaRP had a nearly efficacy to TURP and PKRP based on IPSS, QoL, Qmax, and PVR. Although ThuVaRP was associated with longer operation time, it got distinct superiority on serum hemoglobin decreased, catheterization time, and hospital stay.

Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA, S. Members of the Florey Adelaide Male Ageing (2011) Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol 29(2):179–184CrossRefPubMed

Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W et al (2002) Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care–the Triumph project. Eur Urol 42(4):323–328CrossRefPubMed

Kupelian V, Wei JT, O’Leary MP, Kusek JW, Litman HJ, Link CL et al (2006) Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 166(21):2381–2387CrossRefPubMed

Al-Rawashdah SF, Pastore AL, Salhi YA, Fuschi A, Petrozza V, Maurizi A et al (2017) Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes. World J Urol 35(10):1595–1601CrossRefPubMed

Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 50(5):969–979 (discussion 980) CrossRefPubMed

Nuhoglu B, Ayyildiz A, Karaguzel E, Cebeci O, Germiyanoglu C (2006) Plasmakinetic prostate resection in the treatment of benign prostate hyperplasia: results of 1-year follow up. Int J Urol 13(1):21–24CrossRefPubMed

Reich O (2009) Bipolar transurethral resection of the prostate: what did we learn, and where do we go from here? Eur Urol 56(5):796–797CrossRefPubMed

Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19(1):25–31CrossRefPubMed

Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix VapoResection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 25(3):257–262CrossRefPubMed

10.

Bach T, Xia SJ, Yang Y, Mattioli S, Watson GM, Gross AJ et al (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168CrossRefPubMed

11.

Xia SJ, Zhang YN, Lu J et al (2005) Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia. Nat Med J China 45:62–65

12.

Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian J Androl 11(3):277–281CrossRefPubMedPubMedCentral

13.

Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed

14.

Zhu Y, Zhuo J, Xu D, Xia S, Herrmann TR (2015) Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis. World J Urol 33(4):509–515CrossRefPubMed

15.

Zhao C, Yang H, Chen Z, Ye Z (2016) Thulium laser resection versus plasmakinetic resection of prostates in the treatment of benign prostate hyperplasia: a meta-analysis. J Laparoendosc Adv Surg Tech A 26(10):789–798CrossRefPubMed

16.

Luo B, Zhao X, Lu L et al (2013) The comparison of 2 microns laser five points method vaporization resection and plasma bipolar electrotomy for curative effect of high-risk prostatic hyperplasia. China J Endosc 02:155–157

17.

Hou Y, He Y, Wang H, Zhu W (2016) Thulium laser VapoResection of prostate versus transurethral plasmakinetic resection of prostate for aged and high-risk. Chin J Gerontol 08:1939–1940

18.

Liu C, Li N, Liu Y, Wang P (2011) Thulium laser VapoResection of prostate versus transurethral plasmakinetic resection of prostate for BPH patients. Chin J Laser Med Surg 02:102–105

19.

Sun Y, Luo G, Sun Z et al (2011) A comparative study on the results of two micron laser VapoResection of prostate and bipolar transurethral plasmakinetic prostatectomy for benign prostatic hyperplasia. China J Endosc 07:687–691

20.

Sheng Yang, Jia Liu, Jun Zhang (2015) Comparison of 2 μm continuous-wave laser VapoResection and transurethral resection of the prostate: a randomized controlled trial. Chin J Min Inv Surg 11:986–989

21.

Zhang C, Liu Z, Hu L, Bai Z, Li X, Huang Y (2009) Comparative study on 2 μm continuous wave laser VapoResection of the prostate and transurethral electrovaporization resection of prostate in treatment of BPH. Mod Prev Med 16:3185–3186

22.

Kim JW, Kim YJ, Lee YH, Kwon JB, Cho SR, Kim JS (2014) An analytical comparison of short-term effectiveness and safety between thulium:yag laser VapoResection of the prostate and bipolar transurethral resection of the prostate in patients with benign prostatic hyperplasia. Korean J Urol 55(1):41–46CrossRefPubMedPubMedCentral

23.

Yang Z, Wang X, Liu T (2013) Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up. Urology 81(2):396–400CrossRefPubMed

24.

Wei H, Shao Y, Sun F, Sun X, Zhuo J, Zhao F et al (2014) Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml. World J Urol 32(4):1077–1085CrossRefPubMed

25.

Cui D, Sun F, Zhuo J, Sun X, Han B, Zhao F et al (2014) A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: 4-year follow-up results. World J Urol 32(3):683–689CrossRefPubMed

26.

Fu WJ, Zhang X, Yang Y, Hong BF, Gao JP, Cai W et al (2010) Comparison of 2-microm continuous wave laser VapoResection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75(1):194–199CrossRefPubMed

27.

Jia Z (2009) Control study on thulium laser orange -decorticating type of prostatectomy with transurethral prostatic electric resection to treat patients with benign prostatic hyperplasia. Chin Nurs Res 09:792–793

28.

Tai S, Fan W, Zhong D, Wang K (2015) Thulium laser transurethral resection of prostate versus transurethral resection of prostate. Clin Educ General Pract 03:314–316

29.

Yan H, Ou TW, Chen L, Wang Q, Lan F, Shen P et al (2013) Thulium laser VapoResection versus standard transurethral resection of the prostate: a randomized trial with transpulmonary thermodilution hemodynamic monitoring. Int J Urol 20(5):507–512CrossRefPubMed

30.

Guzman C, Conaco C (2016) Gene expression dynamics accompanying the sponge thermal stress response. PLoS ONE 11(10):e0165368CrossRefPubMedPubMedCentral

31.

Yang Z, Liu T, Wang X (2016) Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up. Lasers Med Sci 31(9):1797–1802CrossRefPubMed

32.

Szlauer R, Gotschl R, Razmaria A, Paras L, Schmeller NT (2009) Endoscopic VapoResection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique. Eur Urol 55(2):368–375CrossRefPubMed

33.

Mamoulakis C, Ubbink DT, de la Rosette JJ (2009) Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol 56(5):798–809CrossRefPubMed

34.

Sun F, Han B, Cui D, Zhao F, Sun X, Zhuo J et al (2015) Long-term results of thulium laser resection of the prostate: a prospective study at multiple centers. World J Urol 33(4):503–508CrossRefPubMed

35.

Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS et al (2008) Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for VapoResection of the prostate. J Endourol 22(5):1041–1045CrossRefPubMed

36.

Fried NM (2005) High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 microm. Lasers Surg Med 36(1):52–56CrossRefPubMed

37.

Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 109(3):408–411CrossRefPubMed

38.

Elzayat EA, Elhilali MM (2007) Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52(5):1465–1471CrossRefPubMed

Title: Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis
Authors: Zheng Deng
Menghao Sun
Yiping Zhu
Jian Zhuo
Fujun Zhao
Shujie Xia
Bangmin Han
Thomas R. W. Herrmann
Publication date: 01-09-2018
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 9/2018
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2287-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2018

Suprapubic versus urethral catheter drainage in robotic-assisted laparoscopic prostatectomy: advancing systematic review quality

Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder

Thermal effects of Ho: YAG laser lithotripsy: real-time evaluation in an in vitro model

The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer

Epidemiology and screening for renal cancer

Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer